Titlebook: New Weapons to Control Bacterial Growth; Tomas G. Villa,Miguel Vinas Book 2016 Springer International Publishing Switzerland 2016 Antibiot

hydroxyapatite

書目名稱New Weapons to Control Bacterial Growth影響因子(影響力)




書目名稱New Weapons to Control Bacterial Growth影響因子(影響力)學(xué)科排名




書目名稱New Weapons to Control Bacterial Growth網(wǎng)絡(luò)公開度




書目名稱New Weapons to Control Bacterial Growth網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱New Weapons to Control Bacterial Growth被引頻次




書目名稱New Weapons to Control Bacterial Growth被引頻次學(xué)科排名




書目名稱New Weapons to Control Bacterial Growth年度引用




書目名稱New Weapons to Control Bacterial Growth年度引用學(xué)科排名




書目名稱New Weapons to Control Bacterial Growth讀者反饋




書目名稱New Weapons to Control Bacterial Growth讀者反饋學(xué)科排名

nonchalance

Fecal Matter Implantation as a Way to Fight Diarrhea-Causing Microorganisms,udes additional topics, such as the effect of probiotics and ADP-ribosylation, as well as cAMP, cGMP, and phosphatidylinositol signaling. We also deal here with the problems associated with fecal transplant therapies when using human stool donors that, although asymptomatic, are in fact carriers of bacterial or parasite diseases.

前奏曲

疲勞

灰姑娘

無表情

,The Case of Lipid II: The Achilles’ Heel of Bacteria,sis, hence causing bacterial lysis. We will concentrate here on several lipid II-acting lantibiotics, such as telavancin, vancomycin, and plusbacin. Additionally, human defensins and moenomycins will be also mentioned, as they constitute putative future biomolecules to fight bacterial infections.

束以馬具

The Biological Fight Against Pathogenic Bacteria and Protozoa,sive absorptive surface composed of a layer of epithelial cells as well as a paracellular barrier. The permeability of this paracellular barrier is regulated by transmembrane proteins known as claudins that play a critical role in tight junctions.

MELD

sistant microorganisms.Suggests new research approaches.ProvWritten by specialists in the different fields, this book presents new perspectives and insights into strategies and weapons to fight microbial infections. It also reviews the “state of the art” of alternative treatment approaches and new t

infantile

可憎

Bacterial Proteases as Targets to Control Bacterial Growth,ll growth. The emergence resistances to traditional antibiotics have created clinical difficulties for nosocomial treatment on a global scale. Thus the pharmacological development of new PRs inhibitors that target essential proteins in the bacterial pathogen is of great interest, and it is the focus of this review.